Ng IOL - Search Results

1

Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain-Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma.

Leung CON, Tong M, Chung KPS, Zhou L, Che N, Tang KH, Ding J, Lau EYT, Ng IOL, Ma S, Lee TKW. Leung CON, et al. Among authors: ng iol. Hepatology. 2020 Jul;72(1):155-168. doi: 10.1002/hep.30989. Epub 2020 Mar 31. Hepatology. 2020. PMID: 31610028

2

Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines.

Lee TK, Lau TC, Ng IO. Lee TK, et al. Cancer Chemother Pharmacol. 2002 Jan;49(1):78-86. doi: 10.1007/s00280-001-0376-4. Cancer Chemother Pharmacol. 2002. PMID: 11855756

3

Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.

Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, Lee TK, Tsui SH, Ng IO, Zhang ZW, Wong J. Man K, et al. Ann Surg. 2003 Feb;237(2):256-64. doi: 10.1097/01.SLA.0000048976.11824.67. Ann Surg. 2003. PMID: 12560784 Free PMC article.

4

Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts.

Man K, Lo CM, Lee TK, Li XL, Ng IO, Fan ST. Man K, et al. Liver Transpl. 2003 Apr;9(4):425-32. doi: 10.1053/jlts.2003.50066. Liver Transpl. 2003. PMID: 12682897 Free article.

5

Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway.

Lee TK, Man K, Ling MT, Wang XH, Wong YC, Lo CM, Poon RT, Ng IO, Fan ST. Lee TK, et al. Carcinogenesis. 2003 Nov;24(11):1729-36. doi: 10.1093/carcin/bgg145. Epub 2003 Aug 29. Carcinogenesis. 2003. PMID: 12949053

6

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, Siu CW, Sander TJ, Bourne EJ, Hall JG, Condreay LD, Lai CL. Yuen MF, et al. Hepatology. 2004 Jun;39(6):1694-701. doi: 10.1002/hep.20240. Hepatology. 2004. PMID: 15185311

7

Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.

Lee TK, Man K, Poon RT, Lo CM, Ng IO, Fan ST. Lee TK, et al. Oncol Rep. 2004 Jul;12(1):25-31. Oncol Rep. 2004. PMID: 15201954

8

Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma.

Yam JW, Ko FC, Chan CY, Yau TO, Tung EK, Leung TH, Jin DY, Ng IO. Yam JW, et al. Hepatology. 2006 Oct;44(4):881-90. doi: 10.1002/hep.21339. Hepatology. 2006. PMID: 17006924

9

Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.

Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Wong CM, et al. Hepatology. 2007 May;45(5):1129-38. doi: 10.1002/hep.21578. Hepatology. 2007. PMID: 17464989

10

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Ma S, et al. Gastroenterology. 2007 Jun;132(7):2542-56. doi: 10.1053/j.gastro.2007.04.025. Epub 2007 Apr 15. Gastroenterology. 2007. PMID: 17570225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters